Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MR-MC-01 for underactive bladder (Phase 1/2a, single-center)
KCT0009028Phase 2Not yet recruiting
- Sponsor
- Mirae Cell Bio
- Start
- Dec 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of MR-MC-01 in Detrusor hypocontractility, sponsored by Mirae Cell Bio. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
MR-MC-01
03
Conditions
Detrusor hypocontractility
Beyond the preview
Go deeper on KCT0009028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0009028.